And also conventional treatments with Lupron (leuprolide) or Zoladex (goserelin) is frequently not readily available and/or way too costly. Lately designed ADT treatments which include abiraterone and enzalutamide are solely out of achieve monetarily for many African sufferers and often not readily available at all in small- and reduce-middle-money